ArticleFrontiers in digital health2026
Machine learning prediction of oxygen therapy in pediatric Mycoplasma pneumoniae pneumonia.
Article in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Explainable machine learning for diagnosing severeFrontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mycoplasma pneumoniae pneumonia represents a significant cause of community-acquired pneumonia in children, with clinical presentations ranging from mild to severe forms requiring respiratory support. Early identification of children at risk for oxygen therapy remains challenging using conventional clinical and laboratory parameters. Methods: We conducted a multicenter retrospective study involving 206 pediatric patients (aged 1 month to 18 years) with confirmed Mycoplasma pneumoniae pneumonia admitted to three Italian hospitals between 2023 and 2025. Nine machine learning algorithms were developed and validated using routine admission data including demographics, clinical presentation, laboratory tests, and imaging findings. The primary outcome was the need for oxygen therapy during hospitalization. Model performance was evaluated using area under the curve (AUC), precision, recall, and F1-score metrics. Feature importance was assessed using SHAP (Shapley Additive Explanations) analysis. Results: Among the 206 patients, 42 (20.4%) required oxygen therapy during hospitalization. The cohort had a mean age of approximately 4.6 years (SD ≈ 3.5), with comorbidities present in approximately 40% of cases. Support Vector Machine (SVM) achieved the highest performance with an AUC of 0.97, precision of 0.93, recall of 0.93, and F1-score of 0.92. Logistic Regression (AUC 0.95), XGBoost (AUC 0.94), and LightGBM (AUC 0.93) also demonstrated strong predictive performance. SHAP analysis consistently identified C-reactive protein (CRP), lactate dehydrogenase (LDH), neutrophil-to-lymphocyte ratio (NLR), neutrophil percentage, and respiratory distress as the most important predictive features across models. Conclusion: Machine learning models using routine admission data can accurately predict oxygen therapy requirements in pediatric Mycoplasma pneumoniae pneumonia. The integration of interpretable artificial intelligence approaches may enable earlier risk stratification and improve clinical decision-making in pediatric respiratory infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.